H.C. Wainwright maintains RVL Pharmaceuticals at 'buy' with a price target of $4.00

An analyst from H.C. Wainwright maintained RVL Pharmaceuticals (NASDAQ: RVLP) at 'buy' and a price target of $4.00 from a prior price target of $5.00.
Prior to this rating, RVL Pharmaceuticals had 4 buy ratings, 1 hold ratings, and 0 sell ratings.
For consensus analyst estimates and price targets on RVL Pharmaceuticals, click here. For more news on RVL Pharmaceuticals, click here.
RVL Pharmaceuticals's stock price closed at $0.870. They are down -25% in the last month and down -40.000% in the last 12 months.
According to Investing Pro, RVL Pharmaceuticals's fair value is $1.011, an upside of 16.261%. RVL Pharmaceuticals's fair value comes with a high degree of uncertainty, according to InvestingPro.
Check out RVL Pharmaceuticals's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or